City Therapeutics
PrivateLast Round
Series B
Jun 8, 2026
Total Funding Raised
$264.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
City Therapeutics is a biotechnology company that develops next-generation RNA interference (RNAi) therapeutics designed to silence disease-causing genes by targeting and degrading messenger RNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
City Therapeutics Comparables
Compare City Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanegene Bio | 84% | |
| Atalanta Therapeutics | 79% | |
| Suzhou Ribo Life Science Co., Ltd. | 78% | |
City Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2026 | ||||
| Convertible Debt | May 27, 2025 | ||||
| Series A | Oct 8, 2024 |
City Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series B, Series A |
| Fidelity Management & Research Company | Series B, Series A |
| Invus Opportunities | Series B |
| ARCH Venture Partners | Series A |
| Viking Global Investors | Series B |
| AN Venture Partners | Series B, Series A |
| Casdin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
$100M round led by Viking Global Investors and Sofinnova Investments.
- Oct 8, 2024
$135M round led by ARCH Venture Partners
City Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about City Therapeutics's valuation, stock price, and market status.